Cannabis industry case challenging prohibition hits Supreme Court (Newsletter: October 27, 2025)

*Hemp dispute in Congress; TX medical marijuana expansion; KY medical
cannabis update; Study: More Americans use marijuana than cigarettes*

Subscribe to receive Marijuana Moment’s newsletter in your inbox every
weekday morning. It’s the best way to make sure you know which cannabis
stories are shaping the day.
Get our daily newsletter.

Email address:

Leave this field empty if you're human:

*Your support makes Marijuana Moment possible…*

*Your good deed for the day:* donate to an independent publisher like
Marijuana Moment and ensure that as many voters as possible have access to
the most in-depth cannabis reporting out there.

Support our work at https://www.patreon.com/marijuanamoment

*/ TOP THINGS TO KNOW*

Marijuana companies filed a petition asking the U.S. Supreme Court to take
up their lawsuit that seeks to block the enforcement of federal prohibition
against their state-legal activities.

As Congress considers how to address hemp through pending appropriations
legislation, state attorneys general are circulating a letter asking
lawmakers to “ensure intoxicating THC products are taken off the market”
and Sen. Rand Paul (R-KY) is supporting language to study “best practices”
on state regulation.

Kentucky Gov. Andy Beshear (D) announced that the state now has 15,000
registered medical cannabis patients and that by next week regulators will
have approved businesses in every category—completing the “full process
cycle from cultivation to dispensary.”

The Texas Department of Public Safety adopted changes to medical cannabis
rules to expand patient access by licensing additional dispensaries and
setting security requirements for satellite locations.

A new study shows that more Americans now use marijuana than smoke
cigarettes—”suggesting possible substitution driven by changing harm
perceptions, evolving legislation and shifting norms.”

- “Cigarette-only use declined, while cannabis-only use increased across
nearly all sociodemographic groups.”

The Michigan House Regulatory Reform Committee held a hearing on bills to
change legal marijuana possession limits and alter rules for addressing
cannabis industry violations.

South Dakota cannabis reform advocates expressed alarm after a meeting of
the legislature’s Medical Marijuana Oversight Committee gave
prohibitionists a platform—stoking fears the panel is part of a coordinated
effort to restrict or repeal patient access.

The Oregon Health Authority is seeking to dismiss a lawsuit alleging that
the state’s psilocybin program discriminates against homebound disabled
patients who can’t travel to licensed psychedelic services centers.

Former Idaho Attorney General Jim Jones (R) argues in a new op-ed that the
Trump administration’s attacks on suspected drug boats are a “stupid tactic
because it destroys the evidence and does not allow for interrogation of
the suspects” while also putting military officers “in an untenable
position.”

*/ FEDERAL*

President Donald Trump hosted a roundtable meeting on his administration’s
efforts to combat drug cartels, saying he will not seek congressional
authorization for military strikes on suspected traffickers.

Several Republican senators are raising questions about the Trump
administration’s military attacks on suspected drug boats.

The House bill to federally legalize marijuana got one new cosponsor for a
total of 57.

*/ STATES*

Montana Gov. Greg Gianforte (R) discussed a program to use marijuana
revenue to fund drug treatment that he supports, saying, “I felt if we are
going to hand out a Schedule 1 drug, we might as well use revenues to pay
for addiction recovery.”

The Georgia House Blue-Ribbon Study Committee on Georgia’s Medical
Marijuana and Hemp Policies held its final meeting.

New York regulators’ request for the U.S. Court of Appeals for the Second
Circuit to reconsider a lower court’s ruling on residency privileges in
marijuana licensing was rejected.

Tennessee regulators entered into an agreed declaratory order clarifying
the regulatory framework for hemp-derived cannabinoid product businesses
during the transition to new state regulations.

Arizona regulators announced a recall of marijuana products due to possible
contamination with aspergillus.

Ohio regulators announced recalls of medical cannabis products that aren’t
marked with a universal THC symbol on each serving and that failed
pesticide testing.

Oklahoma regulators announced a recall of medical cannabis products due to
improper testing methods.

Washington, D.C. regulators proposed changes to medical cannabis rules.

Minnesota’s top marijuana regulator acknowledged frustration that
dispensaries are expressing about product availability.

Maryland regulators posted guidance about marijuana business inspections.


*— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug
policy bills in state legislatures and Congress this year. Patreon
supporters pledging at least $25/month get access to our interactive maps,
charts and hearing calendar so they don’t miss any developments.*


*Learn more about our marijuana bill tracker and become a supporter on
Patreon to get access. —*

*/ LOCAL*

The 143rd Judicial District, Texas district attorney is facing a lawsuit
seeking to remove her from office over accusations she has refused to
enforce drug laws amid a viral video she posted of herself smoking
marijuana.

*/ INTERNATIONAL*

The International Criminal Court rejected former Philippine President
Rodrigo Duterte’s challenge to its jurisdiction in a prosecution related to
killings in the nation’s bloody “war on drugs.”

German officials increased the amount of allowable cannabis imports for
medical and scientific purposes.

*/ SCIENCE & HEALTH*

A review concluded that “cannabinoids provide modest, condition-specific
analgesia and should be considered adjunctive rather than first-line
options, reserved for patients unresponsive to conventional therapy.”

A study found that “group psilocybin-assisted therapy plus
[Mindfulness-Based Stress Reduction] was associated with clinically
significant improvement in depressive symptoms without serious [adverse
events] and with greater reduction in symptoms than MBSR alone.”

*/ BUSINESS*

atai Life Sciences and Beckley Psytech Limited announced that the Food and
Drug Administration granted Breakthrough Therapy designation to their
5-MeO-DMT benzoate nasal spray for adult patients with treatment-resistant
depression.

Canadian retailers sold C$498.7 million worth of legal marijuana products
in August.

*Make sure to subscribe to get Marijuana Moment’s daily dispatch in your
inbox.*
Get our daily newsletter.

Email address:

Leave this field empty if you're human:

*Photo courtesy of Chris Wallis // Side Pocket Images.*

The post Cannabis industry case challenging prohibition hits Supreme Court
(Newsletter: October 27, 2025) appeared first on Marijuana Moment.